Clinical Trials Logo

Sarcopenia clinical trials

View clinical trials related to Sarcopenia.

Filter by:

NCT ID: NCT04606745 Active, not recruiting - Sarcopenia Clinical Trials

Increase of Handgrip Strength After the Use of Removable Partial Dentures.

Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

A common goal of the health professions is to keep the elderly functional, preventing sarcopenia and frailty. Is there an association between handgrip strength in partially edentulous elderlies after completing their dentition with removable partial dentures?

NCT ID: NCT04598464 Completed - Sarcopenia Clinical Trials

Effect of Home-Based Exercise Program in Older Adults With Sarcopenia

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

In the prospective, randomized, controlled multi-centre study, 100 patients who were clinically diagnosed with sarcopenia were assigned to either a home-based exercise group or the control group. The home-based exercise program was performed three days per week for 12 weeks. Before and three months after the exercise program, all the patients were evaluated.

NCT ID: NCT04597645 Completed - Sarcopenia Clinical Trials

Prader-Willi Syndrome Body Composition

Start date: May 6, 2020
Phase: N/A
Study type: Interventional

Adults aged over 18 years, with the diagnosis of Prader-willi syndrome will be recruited through the hospital's outpatient clinic for either as intervention group receiving therapeutic elastic band training, or as control group receiving usual care for a total of 16 weeks. Body composition, physical capacity, and serum changes will be assessed before and after the intervention.

NCT ID: NCT04585607 Completed - Clinical trials for Chronic Kidney Disease Requiring Chronic Dialysis

Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia

Start date: October 19, 2020
Phase: Phase 4
Study type: Interventional

The current study will investigate whether long term implementation of expanded hemodialysis (HDx) will effectively decrease serum levels of large uremic toxins and ameliorate progression of sarcopenia in patients with chronic kidney disease requiring hemodialysis.

NCT ID: NCT04584944 Recruiting - Sarcopenia Clinical Trials

Appendicular Skeletal Muscle Mass Study

SmmS
Start date: June 1, 2020
Phase:
Study type: Observational [Patient Registry]

There is a lot of discussion concerning the normal cut-off points of skeletal mass among different populations worldwide. Genetic and environmental differences most probably lead to different measurements. Defining muscle mass in healthy young adults in Greece will provide information that can be used to determine normal ranges of muscle mass of both sexes and consequently define sarcopenia. The aim of the study is to define appendicular skeletal muscle mass reference measurements in healthy young adults in Greece. These values can be used to determine sarcopenia cut-offs according to recommendations.

NCT ID: NCT04574271 Recruiting - Sarcopenia Clinical Trials

Multidimensional Intervention in Pre-frail Patients Older Than 70 Years

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Aging represents a huge advance in society and a health and social challenge. Spain has one of the highest life expectancies in the world, but other countries with the same demographic characteristics are ahead of us in quality adjusted life years. Primary care setting has the main drivers of healthy aging, acting on the early stages of pre-frailty and frailty. Therefore, it is proposed a multicomponent intervention (nutritional and prescription of physical exercise) in patients older than 70 years of the Medina del Campo Health Center, with pre-frailty criteria, in order to measure the changes that this intervention produces in their mild dysfunction and whether it is capable of reversing it or delaying the progression to a state of frailty.

NCT ID: NCT04569487 Recruiting - Sarcopenia Clinical Trials

Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia

Start date: February 11, 2021
Phase: N/A
Study type: Interventional

The objective of this trial is to constitute a cohort of sarcopenic versus non-sarcopenic patients to validate the most relevant biological, imaging, mobility and clinical markers considered individually or in association for the diagnosis of sarcopenic patients.

NCT ID: NCT04552574 Recruiting - Sarcopenia Clinical Trials

Randomized Clinical Trial of HMR(Home Meal Replacement)-Type Omega-3-balanced-diet

Start date: August 19, 2020
Phase: N/A
Study type: Interventional

Investigate whether HMR(Home meal replacement)-type omega-3-balanced-diet can improve clinical laboratory values related to chronic metabolic diseases through reducing lipids and chronic inflammation, and can prevent muscle loss.

NCT ID: NCT04547478 Completed - Sarcopenia Clinical Trials

L1 M1 of LDCT for Low Muscle Mass Measurement

Start date: January 21, 2019
Phase:
Study type: Observational

The first lumbar spine muscle index (L1 MI) on computed tomography (CT) obtained by measuring muscle surface at the first lumbar vertebrae (L1) level is an indicator of total skeletal mass in specific populations. Nevertheless, the utility of L1 MI derived from low dose chest CT (LDCT) in health assessments and relevant cutoff points are unclear.

NCT ID: NCT04546048 Completed - Quality of Life Clinical Trials

The Early Strength Training Program in Post-transplant Liver Cases

Start date: September 19, 2018
Phase: N/A
Study type: Interventional

Liver transplantation (LT) is a current life-saving procedure performed as an open-abdominal surgery for patients with end-stage liver diseases (ESLD). However, a high risk of post-surgical complications is relevant to major intra-abdominal interventions. In managing post-LT recovery, it is important to consider the extending pre-transplant physical status of ESLD patients concerning an impaired exercise capacity, a prolonged period of deconditioning, fatigue and muscle weakness, which leads to global motor impairment and decreased functional capacity. Sarcopenia and physical deconditioning are known as the hallmark features of ESLD. The quality and the quantity of skeletal muscle mass have been closely correlated with post-transplantation mortality in individuals undergoing LT. In addition to chronic deconditioning or myopathy related to chronic liver failure, post-transplant immunosuppressive medication contributes to increased risk for age-related decline in muscular strength and physical ability. It reportedly persists impaired physical function including reduced muscle strength, which have been consistently associated with impaired quality of life after a liver transplant. Exercise interventions in solid-organ recipients provide improvements in physical function including skeletal muscle strength. The literature has defined many types of exercise-based interventions including aerobic and resistive training or physical activity counselling in improving physical performance tasks, muscle strength and physical domain of quality of life in postoperative liver transplanted adults. Although there are studies in improving muscle performance and functional status, no study conducted in the post-transplant early period and an optimal exercise regimen for post-liver recipients. In the present study, it will be provided a framework for a possible change in practice aiming to improve muscle strength and functionality in liver recipients through a strength training exercise intervention at the early post-transplant period. The purposes of this trial were: 1) to evaluate the feasibility and safety of a strength exercise training program on functional mobility and quality of life of liver transplanted individuals and 2) to initiate physiotherapy protocols in this population. A key component of this approach was that it was individualized, providing one-to-one therapy with tailored progression specific to a person's individual mobility goals.